Squarepoint’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
+42,693
New +$2.02M ﹤0.01% 2308
2025
Q3
Sell
-13,548
Closed -$651K 4870
2025
Q2
$651K Buy
13,548
+1,386
+11% +$60.3K ﹤0.01% 3039
2025
Q1
$488K Sell
12,162
-34,356
-74% -$1.45M ﹤0.01% 3320
2024
Q4
$2.13M Sell
46,518
-42,415
-48% -$1.9M ﹤0.01% 2347
2024
Q3
$4.17M Buy
88,933
+21,522
+32% +$981K 0.01% 1536
2024
Q2
$2.85M Buy
67,411
+2,105
+3% +$92.3K ﹤0.01% 1785
2024
Q1
$2.89M Buy
65,306
+27,431
+72% +$1.25M 0.01% 1853
2023
Q4
$1.74M Buy
37,875
+30,162
+391% +$1.28M ﹤0.01% 2102
2023
Q3
$331K Sell
7,713
-42,168
-85% -$1.97M ﹤0.01% 3096
2023
Q2
$2.38M Buy
+49,881
New +$2.4M 0.01% 1544
2023
Q1
Sell
-13,611
Closed -$720K 3699
2022
Q4
$720K Buy
13,611
+4,241
+45% +$209K ﹤0.01% 2057
2022
Q3
$410K Buy
+9,370
New +$463K ﹤0.01% 2301
2022
Q1
Sell
-10,816
Closed -$637K 3385
2021
Q4
$637K Sell
10,816
-19,648
-64% -$1.13M ﹤0.01% 1990
2021
Q3
$1.67M Buy
+30,464
New +$1.7M ﹤0.01% 1297
2021
Q2
Sell
-7,637
Closed -$394K 3607
2021
Q1
$394K Sell
7,637
-9,417
-55% -$517K ﹤0.01% 2204
2020
Q4
$956K Buy
+17,054
New +$910K 0.01% 1367
2020
Q3
Sell
-19,814
Closed -$899K 2778
2020
Q2
$899K Buy
+19,814
New +$887K 0.01% 1000
2020
Q1
Sell
-61,384
Closed -$2.2M 2385
2019
Q4
$2.2M Buy
61,384
+39,713
+183% +$1.48M 0.01% 852
2019
Q3
$758K Sell
21,671
-19,809
-48% -$762K 0.01% 1405
2019
Q2
$1.78M Buy
+41,480
New +$1.72M 0.02% 911
2018
Q4
Sell
-9,728
Closed -$391K 2193
2018
Q3
$391K Buy
+9,728
New +$389K ﹤0.01% 1416
2018
Q1
Sell
-67,013
Closed -$2.2M 2060
2017
Q4
$2.2M Sell
67,013
-8,941
-12% -$308K 0.04% 528
2017
Q3
$2.54M Sell
75,954
-32,678
-30% -$1.13M 0.05% 440
2017
Q2
$3.86M Buy
108,632
+65,370
+151% +$2.21M 0.08% 316
2017
Q1
$1.33M Buy
+43,262
New +$1.33M 0.04% 507

Other funds holding QGEN

Squarepoint's QGEN Position: Q1 2026 in Review

Squarepoint opened a new position in Qiagen (QGEN) in Q1 2026: 42,693 shares worth $1.71M. The stake represents ﹤0.01% of the portfolio and ranks #2308 among its holdings. This is a return to the name: Squarepoint previously reported a position in QGEN as recently as Q2 2025.

Squarepoint first reported a position in QGEN in Q1 2017 and has held it in 25 quarters since. The position peaked at $4.17M in Q3 2024. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Squarepoint held 42,693 shares of Qiagen worth $1.71M as of Q1 2026.
  • Qiagen was a new Squarepoint position in Q1 2026.
  • Qiagen made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2308 holding.
  • Squarepoint first reported a position in Qiagen in Q1 2017 and has held it in 25 quarters since.
  • Squarepoint's Qiagen position peaked at $4.17M in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.